1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with cystamine in 1 studies
| Studies (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Trials (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Recent Studies (post-2010) (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Studies (cystamine) | Trials (cystamine) | Recent Studies (post-2010) (cystamine) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 1,294 | 4 | 174 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcock, J; Goodson, YJ; Hill, SJ; Khan, RN; Lymn, JS; Warren, AY | 1 |
1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and cystamine
| Article | Year |
|---|---|
Inhibition of tissue transglutaminase 2 attenuates contractility of pregnant human myometrium.
Topics: Bradykinin; Cadaverine; Calcium Signaling; Cystamine; Enzyme Inhibitors; Female; GTP-Binding Proteins; Humans; Imidazoles; In Vitro Techniques; Myometrium; Norleucine; Obstetric Labor, Premature; Oxytocin; Phenylephrine; Pregnancy; Protein Glutamine gamma Glutamyltransferase 2; Tocolysis; Tocolytic Agents; Transglutaminases; Uterine Contraction | 2011 |